DocGo Inc. (DCGO) Debt Components
- 2026-06-30: Notes Payable, CurrentUSD $48.04K; Long-term Debt, Current MaturitiesUSD $48.04K; Long-term Debt, Excluding Current MaturitiesUSD $159.34K; Notes PayableUSD $207.37K.
- 2026-03-31: Notes Payable, CurrentUSD $49.28K; Long-term Debt, Current MaturitiesUSD $49.28K; Long-term Debt, Excluding Current MaturitiesUSD $171.71K; Notes PayableUSD $220.99K.
- 2025-12-31: Notes Payable, CurrentUSD $51.74K; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Notes PayableUSD $235.58K.
- 2025-12-31: Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $51.74K; Long-term Debt, Excluding Current MaturitiesUSD $183.84K; Notes PayableUSD (m).
DocGo Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Notes Payable USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Maximum Amount Outstanding During Period USD | Line of Credit Facility, Increase (Decrease), Net USD | Debt Instrument, Interest Rate, Stated Percentage pure | Line of Credit Facility, Average Outstanding Amount USD | Line of Credit Facility, Interest Rate at Period End pure | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $48.04K | $48.04K | $159.34K | $207.37K | $207.37K | $50.03K | $54.26K | $58.85K | $20.70K | (m) | $23.53K | (m) | (m) | 8.15% | (m) | (m) | (m) |
| 2026-03-31 | $49.28K | $49.28K | $171.71K | $220.99K | $220.99K | $50.03K | $54.26K | $58.85K | $20.70K | (m) | $37.15K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $51.74K | (m) | (m) | $235.58K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $51.74K | $183.84K | (m) | $235.58K | $51.74K | $50.03K | $54.26K | $58.85K | $20.70K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $54.16K | $54.16K | $195.73K | $249.89K | $249.89K | $51.73K | $50.03K | $54.26K | $58.85K | $20.70K | $14.32K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $12.59K | $12.59K | $0.00 | $12.59K | $12.59K | $5.72K | $0.00 | (m) | (m) | (m) | $6.87K | (m) | (m) | 2.50% | (m) | (m) | (m) |
| 2025-03-31 | $12.93K | $12.93K | $2.15K | $15.09K | $15.09K | $5.39K | $0.00 | (m) | (m) | (m) | $9.70K | (m) | (m) | 2.50% | (m) | (m) | (m) |
| 2024-12-31 | $12.52K | (m) | (m) | $17.73K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.50% | (m) | (m) | (m) |
| 2024-12-31 | (m) | $12.52K | $5.21K | (m) | $17.73K | $12.52K | $5.21K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $26.37K | $26.37K | $21.34K | $47.71K | $47.71K | $26.53K | $14.64K | (m) | (m) | (m) | $6.54K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $25.50K | $25.50K | $27.33K | $52.83K | $52.83K | $25.81K | $14.34K | (m) | (m) | (m) | $12.67K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $26.37K | $26.37K | $33.73K | $60.09K | $60.09K | $25.78K | $14.33K | (m) | (m) | (m) | $19.98K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $28.13K | (m) | (m) | $69.72K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $28.13K | $41.59K | (m) | $69.72K | $28.75K | $25.85K | $15.12K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $13.00M | $696.05K | $2.04M | $2.74M | $2.74M | $672.68K | $678.70K | $623.93K | $428.87K | (m) | $180.21K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $17.90M | $696.31K | $1.58M | $2.28M | $2.28M | $571.00K | $563.78K | $492.11K | $273.63K | (m) | $322.10K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $649.81K | $649.81K | (m) | $1.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $664.91K | (m) | (m) | $1.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $664.91K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-11-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $90.00M | $50.00M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $1.00M | (m) | (m) |
| 2022-09-30 | $680.70K | $680.70K | (m) | $2.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $1.00M | (m) | (m) |
| 2022-06-30 | $566.43K | $566.43K | (m) | $1.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $1.00M | (m) | (m) |
| 2022-03-31 | $593.83K | $593.83K | (m) | $1.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $600.45K | (m) | (m) | $1.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $600.45K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-17 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $12.00M | (m) | (m) |
| 2021-09-13 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.00% | (m) |
| 2021-05-13 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 5.00% | (m) |
| 2020-12-31 | $664.36K | (m) | (m) | $1.26M | $142.67K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-10-19 | (m) | (m) | (m) | $71.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | $71.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $71.16K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |